Companies of Artgen Biotech Group are considering entering the markets of a number of friendly countries, Artgen Biotech Chairman of the Board of Directors Artur Isayev said. First to enter foreign markets is likely to be Genetico, which is currently negotiating with potential partners in Kazakhstan and the United Arab Emirates.